bluebird bio, Inc. (LON:0HOH)
3.900
0.00 (0.00%)
At close: Mar 10, 2025
bluebird bio Employees
bluebird bio had 248 employees as of December 31, 2024. The number of employees decreased by 127 or -33.87% compared to the previous year.
Employees
248
Change (1Y)
-127
Growth (1Y)
-33.87%
Revenue / Employee
324.41K GBP
Profits / Employee
-624.12K GBP
Market Cap
36.20M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
bluebird bio News
- 7 days ago - Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions - Business Wire
- 9 days ago - Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity - Benzinga
- 9 days ago - Bluebird bio soars on amended deal with Carlyle, SK Capital - Seeking Alpha
- 9 days ago - Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital - Reuters
- 9 days ago - Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement - Business Wire
- 14 days ago - Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital - Business Wire
- 18 days ago - Carlyle Group, SK Capital secure all regulatory approvals to acquire bluebird bio - Seeking Alpha
- 18 days ago - Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio - Business Wire